Magnetoencephalography in Children

Launched by CHILDREN'S HOSPITAL OF FUDAN UNIVERSITY · Oct 30, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the use of a special brain imaging technique called magnetoencephalography (MEG) to help diagnose various neurodevelopmental disorders in children. These disorders include conditions like epilepsy, autism, ADHD, and others that affect how the brain develops and functions. The goal is to see how well MEG can identify areas in the brain that may have problems, such as where seizures start or if there are brain tumors.

Children aged 1 month to 18 years who have one of the listed conditions can participate in the study. To take part, they should be able to cooperate during the MEG exam, which is a non-invasive procedure that measures brain activity. Families can expect a supportive environment where their child's brain activity will be assessed to help doctors understand their specific needs better. The study is currently looking for participants, and it's a great opportunity for families to contribute to important research that could improve diagnoses and treatments for neurodevelopmental disorders.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. aged 1 month-18 years old (date of investigate minus date of birth)
• • 2. epilepsy
• • 3. intracranial tumors
• • 4. cerebrovascular diseases
• • 5. autism
• • 6. mental retardation
• • 7. ADHD
• • 8. tic disorder
• • 9. neuropsychiatric disorders
• Exclusion Criteria:
• • 1.Unable to cooperate with the exam of MEG